TRVI - Company ID 0001563880
As of 2026-07-09, Trevi Therapeutics, Inc. (TRVI) has a market capitalization of $2.65 B, making it the #1940 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-09 | $2.65 B |
| 2026-07-08 | $2.58 B |
| 2026-07-07 | $2.77 B |
| 2026-07-06 | $2.59 B |
| 2026-07-05 | $2.55 B |
| 2026-07-04 | $2.55 B |
| 2026-07-03 | $2.55 B |
| 2026-07-02 | $2.53 B |
| 2026-07-01 | $2.51 B |
| 2026-06-30 | $2.65 B |
| 2026-06-29 | $2.65 B |
| 2026-06-28 | $2.58 B |
As of 2026-07-09, Trevi Therapeutics, Inc. (TRVI) has a market capitalization of $2.65 B, making it the #1940 most valuable US-listed company.
Trevi Therapeutics, Inc. is the #1940 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-27 | $2.58 B |
| 2026-06-26 | $2.58 B |
| 2026-06-25 | $2.50 B |
| 2026-06-24 | $2.49 B |
| 2026-06-23 | $2.47 B |
| 2026-06-22 | $2.47 B |
| 2026-06-21 | $2.44 B |
| 2026-06-20 | $2.44 B |
| 2026-06-19 | $2.44 B |
| 2026-06-18 | $2.37 B |
| 2026-06-17 | $2.32 B |
| 2026-06-16 | $2.13 B |
| 2026-06-15 | $2.08 B |
| 2026-06-14 | $2.02 B |
| 2026-06-13 | $2.02 B |
| 2026-06-12 | $2.09 B |
| 2026-06-11 | $1.95 B |
| 2026-06-10 | $1.90 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.